Latest Articles

Publication Date
From Endometriosis to Endometriosis-Associated Ovarian Cancer: Molecular Mechanisms, Risk Stratification and Clinical Implications.

Endometriosis is a chronic estrogen-dependent disorder affecting approximately 10% of women of reproductive age. Increasing epidemiological and molecular evidence indicates that it may represent a precursor condition for a subset …

Published: April 14, 2026, midnight
GSK posts encouraging data for endometrial and ovarian cancer drug - London South East

GSK posts encouraging data for endometrial and ovarian cancer drug London South East

Published: April 13, 2026, 6 a.m.
CHCHD2: a bi-organellar fulcrum of mitochondrial homeostasis and reproductive pathology.

Mitochondrial dysfunction has been demonstrated with a role in pathologically driving various obstetric and gynecological (OB/GYN) diseases, but molecular mediators associating mitochondrial dysfunction with discrete pathologies have not been determined …

Published: April 13, 2026, midnight
In ovarian cancer, one drug target towers up to 100-fold above rivals - Stock Titan

In ovarian cancer, one drug target towers up to 100-fold above rivals Stock Titan

Published: April 10, 2026, 11 a.m.
Epigenetic Compound Library Screen Identifies Ibrutinib as an Inhibitor of Ovarian Clear Cell Carcinoma Viability.

Ovarian clear cell carcinoma (OCCC) is an endometriosis-associated ovarian cancer subtype. Somatic mutations in OCCC are reported in ARID1A, PIK3CA, and the TERT promoter (TERTp), as well as less commonly …

Published: April 10, 2026, midnight
Impact of endometriosis on survival outcomes in ovarian cancer patients: a pilot study.

The aim of our study is to investigate the percentage of ovarian cancer (OC) patients with concomitant endometriosis and its distribution across histological subtypes, and to assess whether the presence …

Published: April 9, 2026, midnight
Proseek Bio raises AU$1.5m for ovarian cancer blood test - FemTech World

Proseek Bio raises AU$1.5m for ovarian cancer blood test FemTech World

Published: April 8, 2026, 11 a.m.
Proseek Bio raises AU$1.5m for ovarian cancer blood test - femtechworld.co.uk

Proseek Bio raises AU$1.5m for ovarian cancer blood test femtechworld.co.uk

Published: April 8, 2026, 11 a.m.
Brisbane startup raises $1.5m to commercialise its ovarian cancer detection blood test - Women's Agenda

Brisbane startup raises $1.5m to commercialise its ovarian cancer detection blood test Women's Agenda

Published: April 8, 2026, 1:50 a.m.
SGO 2026 Preview: Endometrial and Ovarian Cancer - Medscape

SGO 2026 Preview: Endometrial and Ovarian Cancer Medscape

Published: March 30, 2026, 5:59 p.m.
Link copied to clipboard!
Subscribe to Our Newsletter

Stay updated with our latest articles!